Clinical Trial Update: Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection

View source ↗

Summary

A long-term follow-up study to evaluate participants with chronic hepatitis B previously treated with AHB-137 injection, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• AHB-137 injection (AHB-137)

Snippet

Sponsor: Ausper Biopharma Co., Ltd. | Conditions: Chronic Hepatitis B | Status: NOT_YET_RECRUITING